Lupin launches Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets) in the US Read more
Pharma MSMEs ask for condition-free time frame of 2-3 years to implement revised Schedule M Read more